Health

Portside -  Doctors have begun trialling the world’s first mRNA lung cancer vaccine in patients, as experts hailed its “groundbreaking” potential to save thousands of lives. Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8m deaths every year. Survival rates in those with advanced forms of the disease, where tumours have spread, are particularly poor.

Now experts are testing a new jab that instructs the body to hunt down and kill cancer cells – then prevents them ever coming back. Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer, the most common form of the disease. 

NBC News -  The World Health Organization's declaration of an mpox public health emergency has touched a nerve with many U.S. students who are fearful of returning to pandemic-era lockdowns and missed social experiences. But CDC officials are quick to point out that an mpox outbreak wouldn’t necessarily lead to school closures. There are a few key reasons — a big one being that mpox doesn’t spread as easily as Covid. Health reporter Erika Edwards reviews everything you need to know about the current mpox spread and how to stay safe.